Pharma plants are awash in data. There are myriad sources: MES for execution status, LIMS (QC results), process historians (equipment conditions), QMS (quality/deviations) to name just a few, but release decisions still stall when those sources disagree or lack an owner. To deal with the chaos, eschbach’s visual factory centers daily work on SQDCP boards…
Laying the groundwork: How pre-planning drives successful facility expansions
In the dynamic world of facility planning and expansion, the initial pre-stages are critical to a project’s success. In advance of diving into feasibility studies, project teams aim to engage in thorough pre-planning discussions to establish clear goals, address logistical challenges, and align design requirements with business needs. Pre-planning is crucial for the success of…
Cellares teams up with Bristol Myers Squibb to explore automated CAR-T cell therapy manufacturing
Less than a week after announcing that it has secured $255 million in Series C funding, South San Francisco-based startup Cellares has revealed that Bristol Myers Squibb has joined its Technology Adoption Partnership (TAP) program. To date, the company has raised more than $355 million in total financing. As part of the TAP program, Bristol…